- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Connect Biopharma Holdings Limited is a biotechnology business based in the US. Connect Biopharma Holdings Limited shares (CNTB) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.26 – an increase of 3.28% over the previous week. Connect Biopharma Holdings Limited employs 81 staff and has a trailing 12-month revenue of around $24.1 million.
What's in this guide?
Our top picks for where to buy Connect Biopharma stock
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Connect Biopharma Holdings Limited stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CNTB. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Connect Biopharma Holdings Limited stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
Compare alternatives
We currently don't have a partnership with that provider but we have other similar offers to choose from:
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Connect Biopharma Holdings Limited stock price (NASDAQ: CNTB)
Use our graph to track the performance of CNTB stocks over time.Connect Biopharma Holdings Limited shares at a glance
Information last updated 2024-10-25.
| Latest market close | $1.26 |
|---|---|
| 52-week range | $0.68 - $2.84 |
| 50-day moving average | $1.24 |
| 200-day moving average | $1.36 |
| Wall St. target price | $6.99 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.39 |
Is it a good time to buy Connect Biopharma Holdings Limited stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Connect Biopharma Holdings Limited price performance over time
Historical closes compared with the close of $1.185 from 2024-10-25
| 1 week (2024-10-22) | -2.87% |
|---|---|
| 1 month (2024-09-30) | -17.70% |
| 3 months (2024-07-30) | -0.42% |
| 6 months (2024-04-30) | -14.75% |
| 1 year (2023-10-30) | -10.90% |
|---|---|
| 2 years (2022-10-28) | 35.77% |
| 3 years (2021-10-29) | 15.84 |
| 5 years (2019-10-26) | N/A |
Connect Biopharma Holdings Limited financials
| Revenue TTM | $24.1 million |
|---|---|
| Operating margin TTM | 24.64% |
| Gross profit TTM | $0 |
| Return on assets TTM | -12.13% |
| Return on equity TTM | -17.92% |
| Profit margin | -88.66% |
| Book value | $2.00 |
| Market Capitalization | $67.4 million |
TTM: trailing 12 months
Connect Biopharma Holdings Limited share dividends
We're not expecting Connect Biopharma Holdings Limited to pay a dividend over the next 12 months.
You may also wish to consider:
- Gilead Sciences (GILD.US) (3.53% forward annual dividend yield)
- Amgen (AMGN.US) (2.86% forward annual dividend yield)
Connect Biopharma Holdings Limited share price volatility
Over the last 12 months, Connect Biopharma Holdings Limited's shares have ranged in value from as little as $0.6777 up to $2.84. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Connect Biopharma Holdings Limited's is -0.346. This would suggest that Connect Biopharma Holdings Limited's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Connect Biopharma Holdings Limited has bucked the trend.
To put Connect Biopharma Holdings Limited's beta into context you can compare it against those of similar companies.
- Gilead Sciences (GILD.US): 0.199
- Vertex Pharmaceuticals (VRTX.US): 0.402
- Amgen (AMGN.US): 0.602
Connect Biopharma Holdings Limited overview
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma, currently under Phase 3 studies; and icanbelimod (formerly CBP-307), an oral small molecule Sphingosine 1-Phosphate Receptor 1 modulator, currently under Phase 2 clinical for the treatment of ulcerative colitis and Crohn's disease. The company was founded in 2012 and is based in San Diego, California. .
Frequently asked questions
nullWhat percentage of Connect Biopharma Holdings Limited is owned by insiders or institutions?
Currently 41.16% of Connect Biopharma Holdings Limited shares are held by insiders and 44.484% by institutions. How many people work for Connect Biopharma Holdings Limited?
Latest data suggests 81 work at Connect Biopharma Holdings Limited. When does the fiscal year end for Connect Biopharma Holdings Limited?
Connect Biopharma Holdings Limited's fiscal year ends in December. Where is Connect Biopharma Holdings Limited based?
Connect Biopharma Holdings Limited's address is: 12265 El Camino Real, San Diego, CA, United States, 92130 What is Connect Biopharma Holdings Limited's ISIN number?
Connect Biopharma Holdings Limited's international securities identification number is: US2075231017
More resources on Finder
More guides on Finder
-
Best broker cash sweep rates of 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
SoFi Invest vs. Robinhood
Compare pros, cons, research tools and reviews for these two trading platforms.
-
10 Best Stock Apps of 2024 to Elevate Your Mobile Trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
SoFi Invest® review 2024: Simple investing, free CFP access
SoFi Invest is a commission-free platform with both active and automated investment accounts.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
How to Invest $20K: 8 Ways to Maximize Earnings
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
-
Robinhood Review 2024: IRA Match and No Commissions
A deep dive into the highlights and limitations of Robinhood.
Ask a question